365 related articles for article (PubMed ID: 35587857)
1. Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy.
Mortezaee K; Majidpoor J
Cell Oncol (Dordr); 2022 Jun; 45(3):333-353. PubMed ID: 35587857
[TBL] [Abstract][Full Text] [Related]
2. [Interleukin-34: a key molecule in the tumor microenvironment].
Kajihara N; Seino KI
Rinsho Ketsueki; 2021; 62(8):1302-1307. PubMed ID: 34497220
[TBL] [Abstract][Full Text] [Related]
3. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
Gao J; Liang Y; Wang L
Front Immunol; 2022; 13():888713. PubMed ID: 35844605
[TBL] [Abstract][Full Text] [Related]
4. IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment.
Liu K; Huang A; Nie J; Tan J; Xing S; Qu Y; Jiang K
Front Immunol; 2021; 12():683332. PubMed ID: 34093586
[TBL] [Abstract][Full Text] [Related]
5. Macrophage Polarization Contributes to the Anti-Tumoral Efficacy of Mesoporous Nanovectors Loaded with Albumin-Bound Paclitaxel.
Leonard F; Curtis LT; Ware MJ; Nosrat T; Liu X; Yokoi K; Frieboes HB; Godin B
Front Immunol; 2017; 8():693. PubMed ID: 28670313
[TBL] [Abstract][Full Text] [Related]
6. Autophagy drives plasticity and functional polarization of tumor-associated macrophages.
Kuo WT; Chang JM; Chen CC; Tsao N; Chang CP
IUBMB Life; 2022 Feb; 74(2):157-169. PubMed ID: 34467634
[TBL] [Abstract][Full Text] [Related]
7. Emerging interleukin targets in the tumour microenvironment: implications for the treatment of gastrointestinal tumours.
Dickerson LK; Carter JA; Kohli K; Pillarisetty VG
Gut; 2023 Aug; 72(8):1592-1606. PubMed ID: 37258094
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Integrative Analysis Reveals the Association of
Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory polarization of engineered heat-inducible macrophages reprogram the tumor immune microenvironment during cancer immunotherapy.
Xue Y; Yan X; Li D; Dong S; Ping Y
Nat Commun; 2024 Mar; 15(1):2270. PubMed ID: 38491004
[TBL] [Abstract][Full Text] [Related]
10. Diverse macrophages polarization in tumor microenvironment.
Rhee I
Arch Pharm Res; 2016 Nov; 39(11):1588-1596. PubMed ID: 27562774
[TBL] [Abstract][Full Text] [Related]
11. M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors.
Choo YW; Kang M; Kim HY; Han J; Kang S; Lee JR; Jeong GJ; Kwon SP; Song SY; Go S; Jung M; Hong J; Kim BS
ACS Nano; 2018 Sep; 12(9):8977-8993. PubMed ID: 30133260
[TBL] [Abstract][Full Text] [Related]
12. SON-1210 - a novel bifunctional IL-12 / IL-15 fusion protein that improves cytokine half-life, targets tumors, and enhances therapeutic efficacy.
Cini JK; Dexter S; Rezac DJ; McAndrew SJ; Hedou G; Brody R; Eraslan RN; Kenney RT; Mohan P
Front Immunol; 2023; 14():1326927. PubMed ID: 38250068
[TBL] [Abstract][Full Text] [Related]
13. Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma.
Yu Z; Li Y; Li Y; Zhang J; Li M; Ji L; Tang Y; Zheng Y; Sheng J; Han Q; Li F; Guo J; Wang L; Sun X; Gao Y; Feng H
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35618286
[TBL] [Abstract][Full Text] [Related]
14. The Multifaceted Role of Macrophages in Oncolytic Virotherapy.
Hofman L; Lawler SE; Lamfers MLM
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452439
[TBL] [Abstract][Full Text] [Related]
15. Distinct patterns of interleukin-12/23 and tumor necrosis factor α synthesis by activated macrophages are modulated by glucose and colon cancer metabolites.
Huang CY; Yu LC
Chin J Physiol; 2020; 63(1):7-14. PubMed ID: 32056981
[TBL] [Abstract][Full Text] [Related]
16. Macrophage polarity in cancer: A review.
Najafi M; Hashemi Goradel N; Farhood B; Salehi E; Nashtaei MS; Khanlarkhani N; Khezri Z; Majidpoor J; Abouzaripour M; Habibi M; Kashani IR; Mortezaee K
J Cell Biochem; 2019 Mar; 120(3):2756-2765. PubMed ID: 30270458
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Macrophage Plasticity in the Tumor Environment: Manipulating Activation State to Improve Outcomes.
Ricketts TD; Prieto-Dominguez N; Gowda PS; Ubil E
Front Immunol; 2021; 12():642285. PubMed ID: 34025653
[TBL] [Abstract][Full Text] [Related]
18. IL-35: New Target for Immunotherapy Targeting the Tumor Microenvironment.
Yi P; Yu W; Xiong Y; Dong Y; Huang Q; Lin Y; Du Y; Hua F
Mol Cancer Ther; 2024 Feb; 23(2):148-158. PubMed ID: 37988561
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.
Zhang SY; Song XY; Li Y; Ye LL; Zhou Q; Yang WB
Pharmacol Res; 2020 Nov; 161():105111. PubMed ID: 33065284
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel-loaded M1 macrophage-derived exosomes for a safe and efficient chemoimmunotherapy of breast cancer.
Zhao Y; Zheng Y; Zhu Y; Li H; Zhu H; Liu T
J Nanobiotechnology; 2022 Aug; 20(1):359. PubMed ID: 35918698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
